Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Walking through the mRNA manufacturing process – and its many challenges.

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Why conversations on gender in drug development must go further.

What did switching from client to constructor teach a seasoned biotech professional?

Could dry vaccines help improve global access to the latest vaccine technologies?